DBCO-PEG4-Ahx-DM1 PEG4)-L-Lysine-PFP ester 10804-10809 (2004)

10804-10809 (2004)

SKP2-C25 exhibits potent antitumor activities in multiple animal models and cooperates with chemotherapeutic agents to reduce cancer cell survival

madecassoside increases the activity of PPAR-γ

Gliotoxin inhibits inducible NF-κB activity by preventing IκB degradation

90 µM and 1

DBCO-PEG4-Ahx-DM1 PEG4)-L-Lysine-PFP ester 10804-10809 (2004)DBCO PEG4 Ahx DM1 is a drug linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO PEG4 Ahx to make antibody drug conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor specific delivery. Product information Molecular Weight: 1297. 92 Formula: C68H89ClN6O17 Chemical Name: [(2R,